Donovan Jones

• 10/17/2024

  Tiny TEN Holdings’ Risky IPO: Can It Overcome Uneven Results and High Valuation?

• 10/7/2024

  **Septerna Seeks $100M IPO for Endocrine and Metabolic Drugs**